Immune IQ has developed, in collaboration with Honeywell, the IQdx platform. It reads health status and disease information from a patient’s immune system to rapidly diagnose critical diseases, many not detectable today. Our powerful diagnostic approach has a much lower cost-per-test, greater range of disease identification and a shorter time to result than other cellular- and mRNA-based approaches. Immune IQ’s initial focus is on one of the world's greatest healthcare challenges – sepsis.